Organon & Co. (historical, later spun off)
E468962
Organon & Co. (historical, later spun off) was Merck & Co.’s women’s health and biosimilars-focused business unit that was separated into an independent pharmaceutical company.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Organon & Co. | 1 |
| Organon & Co. (historical, later spun off) canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4784904 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Organon & Co. (historical, later spun off) Context triple: [Merck & Co., hasSubsidiary, Organon & Co. (historical, later spun off)]
-
A.
Upjohn Company
Upjohn Company was a prominent American pharmaceutical manufacturer founded in the 19th century, known for its innovations in drug formulation and its long-standing presence in Kalamazoo, Michigan.
-
B.
G. D. Searle & Company
G. D. Searle & Company was a major American pharmaceutical firm known for developing products such as the artificial sweetener aspartame (NutraSweet) before being acquired by Monsanto.
-
C.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
-
D.
SmithKline Beckman
SmithKline Beckman was a major American pharmaceutical and diagnostics company formed by the merger of SmithKline and Beckman Instruments, later becoming part of GlaxoSmithKline (GSK).
-
E.
Eagle Pharmacy
Eagle Pharmacy is a historic pharmacy in Kraków, Poland, renowned for its role as a refuge and aid center for Jews during World War II and now preserved as a museum.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Organon & Co. (historical, later spun off) Target entity description: Organon & Co. (historical, later spun off) was Merck & Co.’s women’s health and biosimilars-focused business unit that was separated into an independent pharmaceutical company.
-
A.
Upjohn Company
Upjohn Company was a prominent American pharmaceutical manufacturer founded in the 19th century, known for its innovations in drug formulation and its long-standing presence in Kalamazoo, Michigan.
-
B.
G. D. Searle & Company
G. D. Searle & Company was a major American pharmaceutical firm known for developing products such as the artificial sweetener aspartame (NutraSweet) before being acquired by Monsanto.
-
C.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
-
D.
SmithKline Beckman
SmithKline Beckman was a major American pharmaceutical and diagnostics company formed by the merger of SmithKline and Beckman Instruments, later becoming part of GlaxoSmithKline (GSK).
-
E.
Eagle Pharmacy
Eagle Pharmacy is a historic pharmacy in Kraków, Poland, renowned for its role as a refuge and aid center for Jews during World War II and now preserved as a museum.
- F. None of above. chosen
Statements (30)
| Predicate | Object |
|---|---|
| instanceOf |
business unit
ⓘ
pharmaceutical business unit ⓘ |
| businessType |
biosimilars-focused business unit
ⓘ
women’s health-focused business unit ⓘ |
| corporateAction | separation of women’s health and biosimilars portfolio from Merck & Co. ⓘ |
| corporateRelationship | was internal business segment prior to spin-off ⓘ |
| countryOfParentCompany | United States NERFINISHED ⓘ |
| focusArea |
biosimilars
ⓘ
women’s health ⓘ |
| industry | pharmaceuticals ⓘ |
| parentCompany | Merck & Co., Inc. NERFINISHED ⓘ |
| parentCompanyAlsoKnownAs | Merck Sharp & Dohme (MSD) outside the United States and Canada NERFINISHED ⓘ |
| parentCompanyTicker | MRK NERFINISHED ⓘ |
| partOf | Merck & Co., Inc. NERFINISHED ⓘ |
| predecessorOf | Organon & Co. (independent company) NERFINISHED ⓘ |
| productType |
biosimilar medicines
ⓘ
pharmaceutical products ⓘ |
| reasonForSpinOff | to create a standalone company focused on women’s health and biosimilars ⓘ |
| roleWithinParent | specialized operating unit ⓘ |
| separationType | corporate spin-off ⓘ |
| spunOffInto | Organon & Co. (independent company) NERFINISHED ⓘ |
| statusAfterSpinOff | no longer a business unit of Merck & Co.; operations transferred to independent Organon & Co. ⓘ |
| successorCompanyFocus |
biosimilars
ⓘ
women’s health ⓘ |
| successorCompanyIndustry | global pharmaceutical company ⓘ |
| successorCompanyName | Organon & Co. NERFINISHED ⓘ |
| therapeuticArea |
contraception
ⓘ
fertility ⓘ menopause management ⓘ reproductive health ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Organon & Co. (historical, later spun off) Description of subject: Organon & Co. (historical, later spun off) was Merck & Co.’s women’s health and biosimilars-focused business unit that was separated into an independent pharmaceutical company.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.